These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16168519)

  • 1. Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma.
    Lie-A-Ling M; Bakker CT; Deurholt T; Hoekstra R; Wesseling JG; Afford SC; Bosma PJ
    J Hepatol; 2006 Jan; 44(1):126-33. PubMed ID: 16168519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus expressing mutant p27kip1 enhanced apoptosis against cholangiocarcinoma than adenovirus-p27kip1 wild type.
    Sasaki T; Katayose Y; Suzuki M; Yamamoto K; Shiraso S; Mizuma M; Unno M; Takeuchi H; Lee CT; Matsuno S
    Hepatogastroenterology; 2004; 51(55):68-75. PubMed ID: 15011833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a therapeutic adenoviral vector for cholangiocarcinoma combining tumor-restricted gene expression and infectivity enhancement.
    Nagi P; Vickers SM; Davydova J; Adachi Y; Takayama K; Barker S; Krasnykh V; Curiel DT; Yamamoto M
    J Gastrointest Surg; 2003; 7(3):364-71. PubMed ID: 12654561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
    Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
    Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection.
    Tonouchi A; Ohtsuka M; Ito H; Kimura F; Shimizu H; Kato M; Nimura Y; Iwase K; Hiwasa T; Seki N; Takiguchi M; Miyazaki M
    Am J Gastroenterol; 2006 Jul; 101(7):1601-10. PubMed ID: 16863567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
    Ishikawa K; Sasaki A; Haraguchi N; Yoshikawa Y; Mori M
    Oncologist; 2007 Mar; 12(3):320-4. PubMed ID: 17405896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High promoter activity of cytokeratin-19 gene in cholangiocarcinoma.
    Qin J; Wang M; Qin J; Cai Q; Peng ZH
    Mol Clin Oncol; 2018 Oct; 9(4):467-471. PubMed ID: 30233800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of tenascin in bile duct cancer of hamster liver by combined treatment of dimethylnitrosamine with Opisthorchis viverrini infections.
    Sithithaworn P; Ando K; Limviroj W; Tesana S; Pairojkul C; Yutanawiboonchai W; Chinzei Y; Yoshida T; Sakakura T
    J Helminthol; 2002 Sep; 76(3):261-8. PubMed ID: 12363380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
    Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Yamamoto M; Alvarez RD; Curiel DT
    Gene Ther; 2004 Apr; 11(7):645-8. PubMed ID: 15029227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic gene therapy combined with double suicide genes for human bile duct cancer in nude mouse models.
    Kojima Y; Honda K; Hamada H; Kobayashi N
    J Surg Res; 2009 Nov; 157(1):e63-70. PubMed ID: 19345377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma.
    Ishii T; Yasuchika K; Suemori H; Nakatsuji N; Ikai I; Uemoto S
    Cancer Lett; 2010 Aug; 294(1):25-34. PubMed ID: 20149523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
    Feldmann G; Nattermann J; Nischalke HD; Gorschlüter M; Kuntzen T; Ahlenstiel G; Gerhardt T; Wolff M; Sauerbruch T; Spengler U; Dumoulin FL
    Endoscopy; 2006 Jun; 38(6):604-9. PubMed ID: 16673309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
    Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
    Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
    Liu B; Hervé J; Bioulac-Sage P; Valogne Y; Roux J; Yilmaz F; Boisgard R; Guettier C; Calès P; Tavitian B; Samuel D; Clerc J; Bréchot C; Faivre J
    Gastroenterology; 2007 Apr; 132(4):1495-503. PubMed ID: 17408651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo expression of prostate-specific adenoviral vectors in a canine model.
    Steiner MS; Zhang Y; Carraher J; Lu Y
    Cancer Gene Ther; 1999; 6(5):456-64. PubMed ID: 10505856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
    Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma.
    Zhu ZB; Chen Y; Makhija SK; Lu B; Wang M; Rivera AA; Yamamoto M; Wang S; Siegal GP; Curiel DT; McDonald JM
    Int J Oncol; 2006 Nov; 29(5):1319-29. PubMed ID: 17016667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.